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Background: Over-diagnosis of malaria among African children results in mismanagement of non-malaria infections.
Limited laboratory capacity makes it difficult to implement policies that recommend pre-treatment confirmation of
infections so a new approach with a package for on-the-spot management of fevers was evaluated.
Methods: Febrile children presenting to outpatient clinic were randomized to receive either a ‘test-treat’ package
(history with clinical examination; point-of-care tests; choice of artesunate-amodiaquine, co-amoxiclav and/or
paracetamol) or routine outpatient care in a secondary health care facility in Kumasi, Ghana. A diagnosis of
malaria, bacterial, viral or mixed malarial and bacterial infections was made using pre-defined criteria. Outcome
was resolution of all symptoms including fever on day 7.
Results: The median age of the patients was 37.5 months (IQR: 19 to 66 months), with 56.7% being males.
Compared to routine care the test-treat package resulted in less diagnoses of malaria, (37.2% vs 46.2%, p = 0.190)
and mixed malaria and bacterial infections (14.0% vs 53.8%, p < 0.001) but more diagnoses of viral (33.1% vs 0.0%,
p < 0.001) and bacterial infections only (15.7% vs 0.0%, p < 0.001). Less anti-malarials (51.2% vs 100.0%, p < 0.001)
and antibiotics (29.7% vs 48.7%, p < 0.001), were prescribed in the test-treat group on completion of study, more
test-treat package patients were clinically well (99.2% vs 80.7%, p < 0.001) and febrile (0.8% vs 10.1%, p = 0.001)
and less were admitted for inpatient care (0.0% vs 8.4% p = 0.001) compared to the routine care group.
Conclusion: Test-treat package improves the effectiveness of outpatient diagnosis and treatment of children with
fever and reduces inappropriate prescribing of anti-malarials and antibiotics. The package provides clinicians with
the option for immediate diagnosis and treatment of non-malaria fevers. The test-treat package now needs to be
evaluated in other settings including primary health care facilities.
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The treatment of febrile children makes up approxi-
mately two thirds of the paediatric outpatient workload
in African hospitals [1]. Malaria should be considered in
all febrile children from endemic areas because it is as-
sociated with significant morbidity and mortality [2].
Bacterial infections, such as pneumonia, urinary tract in-
fection, tonsillitis and otitis media, are also common
causes of childhood fever and may be responsible for* Correspondence: ekameyaw@yahoo.com
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unless otherwise stated.more child mortality than malaria, even in malaria en-
demic areas [3]. When left untreated, these bacterial in-
fections can lead to permanent organ damage and death.
However, many of these febrile children will have self-
limiting viral infections. They will not benefit from anti-
malarial drugs and/or antibiotics and should not be put
at unnecessary risk of side effects [3].
Appropriate prescribing or withholding of drugs for in-
fections is not only important for effective treatment and
to avoid unnecessary side effects but it is also essential to
minimize the risk of organisms developing drug resist-
ance. Although many hospitals have access to microscopy
for the diagnosis of malaria [4], fever in children is oftenal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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diagnosis of malaria is common [6] and could have con-
tributed to widespread resistance to anti-malarials, such as
chloroquine [7,8]. Antibiotic resistance is also widespread
[9,10] and it is, therefore, essential that clinicians obtain a
definitive diagnosis of fever so that the right drugs can be
prescribed.
To be able to rationally prescribe or withhold anti-
infective agents clinicians need to have access to diag-
nostic tests for the most common infections and to use
the test results appropriately as guide. Trials have dem-
onstrated the effectiveness of ‘point-of-care’ tests such
as malaria Rapid Diagnostic Tests (RDT) and urine dip-
stick tests for providing specific diagnoses of infections
[6,11] in the African clinic setting [12,13]. RDTs for
Plasmodium falciparum malaria provide accurate diag-
nosis within a few minutes [14-16] and anti-malarial
treatment can be safely withheld if the result is negative
[3]. Urine dipstick tests have good specificity for infec-
tion, and provide a significant improvement on clinical
assessment alone in settings where culture is not available
[12,17]. In this study, the feasibility of a simple test-treat
package for children with fever presenting to outpatient
clinic in a Ghanaian district hospital was assessed to find
out whether the package resulted in better clinical out-
come than the existing routine care. The test-treat pack-
age was based on a structured clinical examination and
easily available point-of-care tests and drugs. The package
content was compliant with national treatment guidelines
so that if it is proved to be effective it has the potential to
be scaled up.
Methods
Study site
The study was conducted at the outpatient clinic of
Suntreso Government Hospital (SGH), a secondary
health care facility in Kumasi, Ghana between August
and October 2009 during the high malaria transmission
season. SGH is a district hospital with 57 inpatient
beds. In 2007, 22,322 children were seen and treated at
the SGH outpatient clinic and 55.7% were treated as
malaria. The hospital laboratory performed blood films
for malarial parasites, haemoglobin estimations, auto-
mated blood cell counts, urinalysis and stool micros-
copy, but had no microbiological culture facilities, and
clinicians did not have access to RDTS.
Diagnosis and treatment
All children between 6 months and 12 years of age pre-
senting to the out-patient department with a temperature
above 37.5°C or a history of fever were recruited into
the study after their caregivers have signed informed
consent form. Children requiring admission or referral
due to severe illness at presentation as defined by WorldHealth Organization’s (WHO) Integrated Management
of Childhood Illness (IMCI) criteria [18] were excluded.
Children were randomized to receive either the test-treat
package (intervention group) or routine outpatient hospital
care (control group). Computer generated 1:1 randomization
was done in blocks of 20 patients and used as the basis for
the randomization. The results of randomization were placed
in sealed envelopes which were opened only when a patient
was enrolled into the study. The patients in the test treat
package were managed by two clinicians from KATH
whereas the patients in the routine care group were man-
aged by the clinicians at SGH. The clinicians in the two
groups had the same level of training and experience.
The test trest-package consisted of rapid diagnostic
test for malaria, urine dipstick test for urinary tract in-
fection (UTI) and examination of ear, nose and throat,
chest and treat with antipyretic with or without anti-
malarials and/or antibiotic for any patient presenting
with fever or history of fever. This package assumes that
urine dipstick test for UTI is comparable to urinalysis,
and rapid diagnostic test is comparable to blood film for
malaria parasites.
Routine care comprised of outpatient registration, tri-
age of patients by nurses, and care given by attending
doctors to patient which consists of history, general
examination, followed by either laboratory request or
direct treatment based on history and examination by
doctors at SGH. The test treat package (intervention)
was tested against routine out patient management of
fever by doctors at SGH (control). Patients randomized
to the test-treat group underwent a structured clinical
examination consisting of ear, nose, throat and joint in-
spection and chest auscultation after their history had
been taken. A bed side malaria RDT for all Plasmodium
species (Parascreen; Zephyr Biomedicals, India) was per-
formed according to the manufacturer’s specifications.
Thick and thin blood films for malaria was done for all
participants in the intervention group. All the RDTs
were done and interpreted by one of the authors (EA) to
eliminate inter-observer bias. A urine sample was ob-
tained from each child in the intervention group, either
spontaneously or by catheterization for children under
two years old who could not produce urine on demand.
These were then immediately tested at the bedside for
nitrites and leucocytes using combi-10 urine dipsticks.
Samples that tested positive for nitrite and/or leucocytes
were transported immediately to the microbiology la-
boratory of the local Teaching Hospital (KATH) for cul-
ture and sensitivity.
Diagnoses made as a result of these clinical and la-
boratory examinations were based on predefined criteria
(Table 1). Patients were thus categorized as having “malaria
only”, “bacterial infection only”, “possible viral infection” or
“mixed malaria and bacterial infection”. Patients diagnosed
Table 1 Definition and treatment of illnesses in febrile children in intervention group
Diagnosis Definition Treatment
Malaria infection Positive malaria RDT Artesunate-amodiaquine
for 3 complete days
Bacterial infection Clinical signs of infection on examination of ears, throat and joints, or chest
auscultation (e.g. redness, exudates, inflammation, lower chest wall in-drawing,
signs of consolidation) and/or urine dipstick positive for nitrites and/or leucocytes
Amoxicillin-clavulanic acid
for 7 days
Possible viral infection Normal clinical examination, negative malaria RDT and negative urine dipstick Paracetamol (as required)
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sunate and amodiaquine (Coarsucam®, Sanofi aventis) in
accordance with Ghana Health Service guidelines [19].
Those diagnosed as “bacterial infection only” were treated
with an amoxicillin-clavulanic acid combination (Amoksi-
clav®, Sandoz). This antibiotic was selected because of its
effective cover for common childhood infections such as
respiratory tract infections, urinary tract infections and
bacteraemia [20,21]. Children with diagnosis of “malaria
and bacterial infection” received both artesunate and amo-
diaquine and amoxicillin-clavulanic acid. A patient with
history of fever and normal clinical examination, negative
malaria RDT and negative urine dipstick results was diag-
nosed as having a “possible viral illness” and received para-
cetamol only because such patient did not need antibiotic
and/or anti-malarial.
Patients in the routine care group received the routine
care provided by the clinicians at SGH. These clinicians
manage patients based on the recommendation of the
Ghana Health Service treatment guidelines [19]. Deci-
sions on clinical examinations, investigations and drug
prescriptions were left completely to the discretion of
the attending clinician in accordance with their routine
management practices. A wide range of antibiotics and
anti-malarials were available to the clinicians at SGH.
They were not informed about the content of the test-
treat package and they did not know that they were in-
volved in the study. This was to prevent them from
changing their routine practice of fever management of
children (Hawthorne effect). The clinical decisions of
the clinicians in the routine group were not interfered
by the clinicians in the intervention group. There was
also no interchange of patients or clinicians between the
intervention and control groups.
Blood and urine samples collected from patients in the
intervention group were transported to a laboratory at
KATH. The blood film slides were examined independ-
ently by two experienced microscopists for the presence
of malaria parasites. Discrepant results were reviewed by
a third microscopist who determined the final result.
The purpose of comparing RDT and microscopy results
was to determine the accuracy of the malaria RDT in
the study setting. Urine samples were cultured to deter-
mine the specific pathogenic organisms and the anti-
microbial sensitivity. The management of the childrenwere based on the results of malaria RDT and urine dip-
stick test as well as clinical examination after history.
Patient follow up and clinical outcomes
Patients from both groups who received anti-malarial(s)
and/or antibiotic(s) were requested to return for review
on the second and the seventh day after recruitment.
However, all patients, in the intervention group, who re-
ceived paracetamol only were given appointments for
daily follow up as the sensitivity of the RDT used in the
study was less than 100%. Sensitivity of the RDT used in
this study was 98.0% and specificity is 83.3%. Patients in
both groups who failed to attend their follow up ap-
pointments were visited at their homes to ensure they
were clinically safe. At these reviews all children under-
went a clinical assessment and the result documented.
The patients were assessed by the same sets of clinicians
who had conducted the initial assessment and manage-
ment in the respective groups.
The primary end point for the study was an asymp-
tomatic and afebrile child as reported by the caregiver/
child on day 7. Secondary end points were no symptoms
and no fever on day 2. Information was collected about
the presence of fever and/or symptoms on days 2 and 7.
Patients who had fever at the end of the seventh day
were further assessed and managed appropriately. They
were followed till recovery. All data were collected on a
pre-designed form and entered in a Microsoft Access®
2007 database.
Statistical analyses
Pre-trial power calculations indicated that 120 patients
would be needed in each of the intervention and routine
care groups to detect a difference of 15% in the absolute
treatment failure rates between the two groups. In this
sample size there was an estimation of a two sided type I
error of 0.05, a power of 80%, an absolute failure rate of
25% in the routine treatment group and an anticipated
non-response/dropout rate of 15% were used. The data
were transferred from Microsoft Access 2007 to Stata
10.1 (StataCorp, Texas 77845, USA) from which univari-
ate analysis with point estimates and 95% confidence in-
tervals of baseline characteristics of the children were
calculated. Bivariate analysis was performed using the
Fischer’s test. Based on blood film analysis, sensitivity,
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ive value for the RDT compared to malaria parasite
blood film microscopy (gold standard) in this setting
were also calculated.
Results
Initial diagnosis and treatment
The median age of the patients in the study was
37.5 months (IQR: 19 to 66 months) with 56.7% being
males. The median age, age range and sex distribution
were similar in both groups. One patient was inadvert-
ently recruited into the intervention group resulting in
121 patients in intervention group and 119 in the rou-
tine care group (Figure 1). The caregivers of the patients
in both groups had similar educational levels and previ-
ous medication histories (Table 2). Overall 175 (72.9%,
95% CI: 66.8 to 78.4%) of the 240 patients had taken
medication in the week preceding the study. 160 (66.7%,
95% CI: 60.3 to 72.6%) had taken paracetamol, 15 (6.2%,
95% CI: 3.5% to 10.1%) had amodiaquine, 12 (5.0%, 95%
CI: 2.6 to 8.6%) had amoxicillin and 7 (2.9%, 95% CI:
1.2% to 5.9%) had artesunate. Some clinical features dif-
fered between the two groups with poor feeding, diar-
rhoea, cough, inflamed tonsils and rhinorrhoea occurring
more frequently in the routine care group. The severity of
febrile illness was comparable among the two groups. The
mean (and standard) deviations of temperature and re-
spiratory rates in the intervention and control groups at
recruitment were 38.5 (0.9); 38.5 (0.9); and 32.0 (10.2);
31.3 (11.1), respectively.Figure 1 Trial profile.At initial assessment, all 121 patients in the interven-
tion group had malaria RDT performed but only one of
the 119 patients in the routine care group had a blood
film requested for malaria screening. Urine dipstick was
positive for nitrites and/or leucocytes in 16 (13.2%, 95%
CI: 7.7% to 20.6%) patients in the intervention group.
Only one patient in the routine care group had urinalysis
performed and it was negative.
There were significant differences among diagnosis
between the groups in diagnosis at presentation (Table 3).
Similar numbers of patients in both groups, 45 (37.2%)
in the intervention group and 55 (46.2%) in the routine
care group, were diagnosed as having malaria alone
but more children in the intervention group were di-
agnosed with suspected viral infection (40[33.1%]
compared to 0[0%]) or possible bacterial infection only
(19[15.7%] compared to 0[0%]). Fewer children in the
intervention group than in the routine care group had
malaria and bacterial co-infection (17[14.0%] compared
to 64[53.8%]). In the routine care group all children were
prescribed anti-malarial drug either alone (61[51.3%])
or in combination with an antibiotic (58[48.7%]). Only
51.2% of children in the intervention group received
anti-malarials either alone (45[37.2%]) or in combin-
ation with an antibiotic (17 [14.0%]). None of the chil-
dren in the routine group were prescribed either
paracetamol alone or an antibiotic alone compared to
the intervention group in which 40 (33.1%) received
paracetamol alone and 19 (15.7%) received an antibiotic
alone.
Table 2 Characteristics of children in the intervention and routine care groups at enrolment
Study group
All patients (N = 240) Test-Treat (N = 121) Routine care (N = 119)
Educational level of carers
None 30 (12.5%) 17 (14.0%) 13 (10.9%)
Primary 123 (51.2%) 66 (54.5%) 57 (47.9%)
Secondary School 66 (27.5%) 26 (21.5%) 40 (33.6%)
Tertiary 21 (8.8%) 12 (9.9%) 9 (7.6%)
Medication taken prior to study
Any Drug 175 (72.9%) 86 (71.1%) 89 (74.8%)
Paracetamol 160 (66.7%) 78 (64.5%) 82 (68.9%)
Amodiaquine 15 (6.2%) 6 (5.0%) 9 (7.6%)
Amoxicillin 12 (5.0%) 9 (7.4%) 3 (2.5%)
Artesunate 7 (2.5%) 4 (3.3%) 2 (1.7%)
Co-amoxiclav 0 (0.0%) 0 (0.0%) 0 (0.0%)
Other drugs 47 (19.6%) 24 (19.5%) 23 (19.7%)
Clinical features at initial assessment
Fever 239 (99.6%) 120 (99.2%) 119 (100.0%)
Temperature, mean (sd) 38.5 (0.9) 38.5 (0.9) 38.5 (0.9)
Poor feeding 165 (68.7%) 75 (62.0%) 90 (75.6%)
Cough 106 (44.2%) 38 (31.4%) 68 (57.1%)
Respiratory rate, mean (sd) 31.4(10.9) 32.0 (10.2) 31.3 (11.1)
Rhinorrhoea 92 (38.3%) 20 (16.5%) 72 (60.5%)
Vomiting 92 (38.3%) 43 (35.5%) 49 (41.2%)
Headache 64 (26.7%) 34 (28.1%) 30 (25.2%)
Diarrhoea 42 (17.5%) 12 (9.9%) 30 (25.3%)
Chills 39 (17.0%) 13 (10.7%) 26 (23.4%)
Inflamed tonsils 14 (5.8%) 13 (10.7%) 1 (0.8%)
Inflamed Eardrum 4 (1.7%) 4 (3.3%) 0 (0.0%)
Sweating 14 (5.8%) 4 (3.3%) 10 (8.4%)
Body pains 10 (4.2%) 4 (3.3%) 6 (5.0%)
Ear pain 6 (2.5%) 3 (2.5%) 3 (2.5%)
Others 12 (5%) 10 (7%) 2 (2%)
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Seven of the 240 patients, three from the intervention
group, failed to come for follow up appointments and
they were traced to their homes and reviewed. This was
to ensure that each patient was clinically safe. At day 2
review, only two (1.6%) of the patients in the interven-
tion group required another laboratory investigation be-
cause of persistent fever compared to 13 (10.9%) in the
routine care group (p = 0.001). There were significant
differences in the clinical outcomes of children in the
two groups by day 7. Fever had resolved in 120 (99.2%)
of children out of 121 in the intervention group com-
pared to 96 (80.7%) out of 119 in the routine treatment
group (p = 0.001). No child in the intervention grouprequired hospitalization whereas in the routine care
group 10 (8.4%) children were hospitalized (p = 0.0001).
One patient (0.8%) in the intervention group remained
febrile at the end of the study compared to 12 (10.1%) in
the control group (p = 0.001).
Accuracy of malaria RDTs in this setting
In the intervention group 60 (49.6%, 95% CI: 40.4% to
58.8%) patients had positive malaria RDTs compared to
49 (40.5%, 95% CI: 31.7% to 41.8%) who had positive
blood films by microscopy. Using microscopy as the gold
standard, the RDT had a sensitivity of 98.0% (95% CI:
89.1% to 99.9%), a specificity of 83.3% (95% CI: 72.7% to
91.1%), a negative predictive value of 98.4% (95% CI:
Table 3 Management and clinical outcomes of children in the intervention and routine care groups
Study group
All patients (N = 240) Intervention (N = 121) Routine care (N = 119) P-value
Initial diagnosis
Malaria 100 (41.7%) 45 (37.2%) 55 (46.2%) 0.190
Malaria plus bacterial infection 81 (33.7%) 17 (14.0%) 64 (53.8%) <0.001
Viral infection 40 (16.7%) 40 (33.1%) 0 (0%) <0.001
Bacterial infection 19 (7.9%) 19 (15.7%) 0 (0%) <0.001
Treatment at initial diagnosis
Artesunate-Amodiaquine only 106 (44.2%) 45 (37.2%) 61 (51.3%) 0.028
Artesunate-Amodiaquine and Antibiotic 75 (31.2%) 17 (14.0%) 58 (48.7%) <0.001
Paracetamol only 40 (16.7%) 40 (33.1%) 0 (0.0%) <0.001
Antibiotic only 19 (7.9%) 19 (15.7%) 0 (0.0%) <0.001
Action taken at day 2 review
Treatment completed 2 (0.8%) 1 (0.8%) 1 (0.8%) 1.000
Continue medication 192 (80.0%) 117 (96.7%) 75 (63.0%) <0.001
Admit for treatment 9 (3.7%) 0 (0.0%) 9 (7.6%) 0.002
Change medication 15 (6.2%) 1 (0.8%) 14 (11.8%) <0.001
Add medication 22 (9.2%) 2 (1.6%) 20 (16.8%) <0.001
Action taken at day 7 review
Treatment completed 223 (93%) 120 (99.2%) 103 (87.3%) <0.001
Continue medication 5 (2.1%) 1 (0.8%) 4 (3.4%) 0.211
Admit for treatment 1 (0.4%) 0 (0.0%) 1 (0.8%) 0.496
Change medication 5 (2.1%) 0 (0.0%) 5 (4.2%) 0.029
Add medication 5 (2.1%) 0 (0.0%) 5 (4.2%) 0.029
Clinical outcome at end of study
Completed treatment and well 216 (90.0%) 120 (99.2%) 96 (80.7%) <0.001
Admitted to hospital 10 (4.2%) 0 (0.0%) 10 (8.4%) 0.001
Remained febrile 13 (5.4%) 1 (0.8%) 12 (10.1%) 0.001
Death 1 (0.4%) 0 (0.0%) 1 (0.8%) 0.496
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80.0% (95%CI: 67.7% to 89.2%).
Discussion
This study assessed the introduction of a simple test-
treat package for management of stable febrile children
in an African out-patient clinic in a secondary health
care facility. The ‘test’ component of the package con-
sisted of a structured examination of ears, nose and
throat, joints and chest, a malaria RDT and urine dip-
stick testing. The ‘treat’ component was guided by the
results of clinical examination and tests, and consisted
of a choice of an anti-malarial (artesunate-amodiaquine),
an antibiotic (co-amoxiclav) or an antipyretic (paraceta-
mol). These drugs were used singly or in combination
according to the diagnosis. The test treat package (inter-
vention) was tested against the routine management
(control) of stable febrile illness among children at theOPD by the doctors at SGH. The test-treat package re-
sulted in resolution of fever in >99% of patients except
one patient who remained febrile at the end of the study
but no child in the test-treat package group required
hospital admission.
In contrast, 10.1% of the patients in the routine care
had fever at the end of the study, and 8.4% required hos-
pital admission. All patients who had fever at the end of
the study were followed up till resolution. Almost all the
patients in the routine care group who were prescribed
anti-malarials had no laboratory confirmation of malaria
infection although blood film microscopy for malaria
was available in the hospital. International and local
guidelines recommend that malaria should be confirmed
if tests are available [19,22] as this will reduce risk of de-
veloping drug resistance and ensure that non-malaria
causes of fever are managed appropriately. The signifi-
cantly higher rates of persistent fever necessitating
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who received routine care compared to those in the
intervention group, reinforces the need for stringent im-
plementation of these recommendations to achieve bet-
ter clinical outcomes.
Despite policies promoting the use of RDTs to investi-
gate fever there is still widespread over-prescribing of
anti-malarials in the face of a negative malaria test. One
reason may be that health workers often do not have any
diagnostic tools for determining the cause of fever and,
because they are concerned about missing a possible mal-
aria infection, they default to prescribing anti-malarials.
The RDT, which is highly effective in diagnosing malaria
as a cause of fever, was included as part of the test-treat
package, but the package also incorporated alternative
diagnostic and treatment strategies for malaria-negative
febrile children. For example, substantial proportions of
patients in the intervention group had positive urine dip-
stick test and were consequently treated with antibiotics
and not with anti-malarials. Failure to seek a definitive
cause for fever in children puts them at risk of long
term complications of the undiagnosed and untreated
infections. For example, persistent, untreated urinary
tract infections can lead to renal scarring, hypertension
and finally chronic renal failure. In addition to the direct
cost of prolonged or alternative courses of treatment
and hospitalizations, ineffective management of febrile
children prolongs ill health and necessitates repeated
visits to health facilities, both of which generate an eco-
nomic and social burden which disproportionately af-
fects families [5,23].
The rate of anti-malarial use in patients who received
routine care was 2.5 times higher than in children who
were managed using the test-treat package. Globally, the
successful control of malaria is dependent on the contin-
ued efficacy of artemisinins. There is already evidence
that resistance to artemisinins is appearing in Southeast
Asia [24,25] and the development of resistance is closely
linked to overuse of drugs. If the results reflect the situ-
ation in other paediatric clinics in malaria endemic areas
of sub-Saharan Africa then a half to two thirds of all
out-patient prescriptions for anti-malarials in children
are unnecessary. This has potentially devastating conse-
quences by promoting the development of drug resist-
ance and jeopardizing efforts to control malaria.
The study had some limitations. The two groups were
managed by two different sets of clinicians. This resulted
from the study design. The authors went to SGH to test
their test treat package against the routine practice of
management of fever by the clinician at SGH. It was also
conducted during the high malaria transmission season
and so the results may not be applicable to areas or sea-
sons with lower transmission rates. However, malaria
over diagnosis rates tend to be higher when transmissionis lower [23] so our results may underestimate the true
benefit of the test-treat package. Possible cross-over ef-
fects in patient management was avoided by using separ-
ate teams of clinicians to manage the two groups of
patients. Both teams of clinicians had the same level of
training and clinical experience. The test-treat package is
practical and effective for reducing inappropriate pre-
scribing and improving health outcomes in febrile chil-
dren but it would be important to evaluate it in a variety
of other settings including in non-hospital settings such
as primary health care clinics. This is a small study of a
specific group of patients which was conducted during
the high malaria transmission period. The diversity of
physicians’ competencies and settings across Africa limit
the generalizability of the study. A multi-centre study
considering different transmission patterns and with a
larger sample size that will enable clustering of patients
is needed to confirm the findings.
The potential benefits of such a simple and affordable
approach for improving health outcomes in patients, for
protecting the economic well-being of their families and
for reducing the potential for drug resistance are immense.
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